Filed: 5/15/2024ACC: 0001104659-24-061728
📋 What this filing means
SOFINNOVA INVESTMENTS, INC. filed this quarterly 13F‑HR report disclosing 69 equity positions with a total reported market value of $1.80B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
69
Positions
$1.80B
Total AUM (reported)
63.19M
Total Shares
Allocation by class
COM$1.26B70.3%
SPONSORED ADR$214.08M11.9%
CL A$120.48M6.7%
S&P BIOTECH$80.66M4.5%
ADR$78.57M4.4%
SHS$34.44M1.9%
COM PAR $.01$2.71M0.2%
Portfolio Concentration
Top 3$376.25M21.0%
4–10$546.92M30.5%
11–25$556.86M31.0%
Rest$315.09M17.6%
Top 3 weight
21.0%
Top 10 weight
51.4%
Voting Authority Distribution
Total shares with voting rights: 63.19M
Sole
Full voting authority
63.19M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole69
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings69
Rows:
Natera Inc
SOLEShares1.55M
TypeSH
Market value$141.79M
7.90%
Sole
1.55M
Shared
0.00
None
0.00
Vera Therapeutics Inc
SOLEShares2.79M
TypeSH
Market value$120.48M
6.71%
Sole
2.79M
Shared
0.00
None
0.00
Ascendis Pharma A/S
SOLEShares754.03K
TypeSH
Market value$113.99M
6.35%
Sole
754.03K
Shared
0.00
None
0.00
Aerovate Therapeutics Inc
SOLEShares3.76M
TypeSH
Market value$111.14M
6.19%
Sole
3.76M
Shared
0.00
None
0.00
Merck & Co Inc
SOLEShares651.30K
TypeSH
Market value$85.94M
4.79%
Sole
651.30K
Shared
0.00
None
0.00
Spdr Ser Tr
SOLEShares850K
TypeSH
Market value$80.66M
4.49%
Sole
850K
Shared
0.00
None
0.00
Novo-Nordisk A S
SOLEShares611.88K
TypeSH
Market value$78.57M
4.38%
Sole
611.88K
Shared
0.00
None
0.00
Incyte Corp
SOLEShares1.33M
TypeSH
Market value$75.61M
4.21%
Sole
1.33M
Shared
0.00
None
0.00
Argenx SE
SOLEShares149.30K
TypeSH
Market value$58.78M
3.27%
Sole
149.30K
Shared
0.00
None
0.00
Intuitive Surgical Inc
SOLEShares140.88K
TypeSH
Market value$56.22M
3.13%
Sole
140.88K
Shared
0.00
None
0.00
Dyne Therapeutics Inc
SOLEShares1.94M
TypeSH
Market value$54.98M
3.06%
Sole
1.94M
Shared
0.00
None
0.00
Inhibrx Inc
SOLEShares1.30M
TypeSH
Market value$45.54M
2.54%
Sole
1.30M
Shared
0.00
None
0.00
Elanco Animal Health Inc
SOLEShares2.56M
TypeSH
Market value$41.60M
2.32%
Sole
2.56M
Shared
0.00
None
0.00
IDEXX Labs Inc
SOLEShares75.22K
TypeSH
Market value$40.62M
2.26%
Sole
75.22K
Shared
0.00
None
0.00
AstraZeneca PLC
SOLEShares596.71K
TypeSH
Market value$40.43M
2.25%
Sole
596.71K
Shared
0.00
None
0.00
Syndax Pharmaceuticals Inc
SOLEShares1.61M
TypeSH
Market value$38.28M
2.13%
Sole
1.61M
Shared
0.00
None
0.00
Insulet Corp
SOLEShares220.20K
TypeSH
Market value$37.74M
2.10%
Sole
220.20K
Shared
0.00
None
0.00
Y-mAbs Therapeutics Inc
SOLEShares2.19M
TypeSH
Market value$35.68M
1.99%
Sole
2.19M
Shared
0.00
None
0.00
IDEAYA Biosciences Inc
SOLEShares781.60K
TypeSH
Market value$34.30M
1.91%
Sole
781.60K
Shared
0.00
None
0.00
Celldex Therapeutics Inc
SOLEShares801.78K
TypeSH
Market value$33.65M
1.87%
Sole
801.78K
Shared
0.00
None
0.00
Inozyme Pharma Inc
SOLEShares4.28M
TypeSH
Market value$32.79M
1.83%
Sole
4.28M
Shared
0.00
None
0.00
Align Technology Inc
SOLEShares95.48K
TypeSH
Market value$31.31M
1.74%
Sole
95.48K
Shared
0.00
None
0.00
Arrivent Biopharma Inc
SOLEShares1.70M
TypeSH
Market value$30.30M
1.69%
Sole
1.70M
Shared
0.00
None
0.00
TG Therapeutics Inc
SOLEShares1.98M
TypeSH
Market value$30.19M
1.68%
Sole
1.98M
Shared
0.00
None
0.00
Sarepta Therapeutics Inc
SOLEShares227.49K
TypeSH
Market value$29.45M
1.64%
Sole
227.49K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Natera IncSOLE | COM | 1.55M | SH | $141.79M 7.90% | 1.55M | 0.00 | 0.00 |
Vera Therapeutics IncSOLE | CL A | 2.79M | SH | $120.48M 6.71% | 2.79M | 0.00 | 0.00 |
Ascendis Pharma A/SSOLE | SPONSORED ADR | 754.03K | SH | $113.99M 6.35% | 754.03K | 0.00 | 0.00 |
Aerovate Therapeutics IncSOLE | COM | 3.76M | SH | $111.14M 6.19% | 3.76M | 0.00 | 0.00 |
Merck & Co IncSOLE | COM | 651.30K | SH | $85.94M 4.79% | 651.30K | 0.00 | 0.00 |
Spdr Ser TrSOLE | S&P BIOTECH | 850K | SH | $80.66M 4.49% | 850K | 0.00 | 0.00 |
Novo-Nordisk A SSOLE | ADR | 611.88K | SH | $78.57M 4.38% | 611.88K | 0.00 | 0.00 |
Incyte CorpSOLE | COM | 1.33M | SH | $75.61M 4.21% | 1.33M | 0.00 | 0.00 |
Argenx SESOLE | SPONSORED ADR | 149.30K | SH | $58.78M 3.27% | 149.30K | 0.00 | 0.00 |
Intuitive Surgical IncSOLE | COM | 140.88K | SH | $56.22M 3.13% | 140.88K | 0.00 | 0.00 |
Dyne Therapeutics IncSOLE | COM | 1.94M | SH | $54.98M 3.06% | 1.94M | 0.00 | 0.00 |
Inhibrx IncSOLE | COM | 1.30M | SH | $45.54M 2.54% | 1.30M | 0.00 | 0.00 |
Elanco Animal Health IncSOLE | COM | 2.56M | SH | $41.60M 2.32% | 2.56M | 0.00 | 0.00 |
IDEXX Labs IncSOLE | COM | 75.22K | SH | $40.62M 2.26% | 75.22K | 0.00 | 0.00 |
AstraZeneca PLCSOLE | SPONSORED ADR | 596.71K | SH | $40.43M 2.25% | 596.71K | 0.00 | 0.00 |
Syndax Pharmaceuticals IncSOLE | COM | 1.61M | SH | $38.28M 2.13% | 1.61M | 0.00 | 0.00 |
Insulet CorpSOLE | COM | 220.20K | SH | $37.74M 2.10% | 220.20K | 0.00 | 0.00 |
Y-mAbs Therapeutics IncSOLE | COM | 2.19M | SH | $35.68M 1.99% | 2.19M | 0.00 | 0.00 |
IDEAYA Biosciences IncSOLE | COM | 781.60K | SH | $34.30M 1.91% | 781.60K | 0.00 | 0.00 |
Celldex Therapeutics IncSOLE | COM | 801.78K | SH | $33.65M 1.87% | 801.78K | 0.00 | 0.00 |
Inozyme Pharma IncSOLE | COM | 4.28M | SH | $32.79M 1.83% | 4.28M | 0.00 | 0.00 |
Align Technology IncSOLE | COM | 95.48K | SH | $31.31M 1.74% | 95.48K | 0.00 | 0.00 |
Arrivent Biopharma IncSOLE | COM | 1.70M | SH | $30.30M 1.69% | 1.70M | 0.00 | 0.00 |
TG Therapeutics IncSOLE | COM | 1.98M | SH | $30.19M 1.68% | 1.98M | 0.00 | 0.00 |
Sarepta Therapeutics IncSOLE | COM | 227.49K | SH | $29.45M 1.64% | 227.49K | 0.00 | 0.00 |
Page 1 of 3